SUPERNUS PHARMACEUTICALS, INC.: Form 8-K filed 2026-10-19
- Accepted by EDGAR
- 2026-10-19 16:51 ET
- Event date
- 2026-10-19
- Accession no.
- 0001356576-26-000043
- Original filing
- SEC EDGAR filing index
Items reported
- Item 2.02: Results of Operations and Financial Condition
The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed".
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | supn-20261019.htm |
| EX-99.1 | EX-99.1 | ex-99110x19xearningscallan.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.